ILMN vs STRO · rev $4.34B vs rev $62.0M
Illumina Inc (ILMN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ILMN currently screens at market cap $15.84B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ILMN and STRO stock pages for the full models.
Not investment advice.